 Theodore Randolph
Concepts (518)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antibodies, Monoclonal | 35 | 2025 | 1366 | 6.760 |
Why?
| | Protein Aggregates | 25 | 2022 | 67 | 5.500 |
Why?
| | Freeze Drying | 44 | 2024 | 82 | 4.880 |
Why?
| | Silicone Oils | 15 | 2017 | 26 | 4.540 |
Why?
| | Recombinant Proteins | 54 | 2019 | 1308 | 4.350 |
Why?
| | Proteins | 32 | 2022 | 944 | 4.160 |
Why?
| | Particle Size | 41 | 2025 | 351 | 4.110 |
Why?
| | Chemistry, Pharmaceutical | 36 | 2021 | 107 | 4.040 |
Why?
| | Drug Stability | 51 | 2024 | 159 | 3.420 |
Why?
| | Immunoglobulin G | 24 | 2020 | 851 | 3.110 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 14 | 2019 | 254 | 3.010 |
Why?
| | Polysorbates | 24 | 2025 | 39 | 2.990 |
Why?
| | Antibody Formation | 13 | 2017 | 291 | 2.930 |
Why?
| | Excipients | 29 | 2025 | 52 | 2.810 |
Why?
| | Ebolavirus | 4 | 2022 | 34 | 2.790 |
Why?
| | Machine Learning | 7 | 2025 | 443 | 2.730 |
Why?
| | Microscopy | 7 | 2025 | 141 | 2.700 |
Why?
| | Drug Compounding | 19 | 2024 | 97 | 2.680 |
Why?
| | Immunoglobulins, Intravenous | 9 | 2021 | 130 | 2.540 |
Why?
| | Surface-Active Agents | 19 | 2020 | 84 | 2.470 |
Why?
| | Human Growth Hormone | 10 | 2014 | 45 | 2.470 |
Why?
| | Vaccines | 5 | 2024 | 400 | 2.310 |
Why?
| | Muramidase | 13 | 2022 | 77 | 2.250 |
Why?
| | Adjuvants, Immunologic | 11 | 2024 | 221 | 2.160 |
Why?
| | Aluminum Hydroxide | 8 | 2019 | 12 | 2.060 |
Why?
| | Water | 24 | 2022 | 441 | 2.050 |
Why?
| | Protein Folding | 34 | 2012 | 265 | 2.040 |
Why?
| | Hemorrhagic Fever, Ebola | 3 | 2021 | 35 | 2.010 |
Why?
| | Nanoparticles | 10 | 2020 | 375 | 1.970 |
Why?
| | Adsorption | 23 | 2025 | 139 | 1.880 |
Why?
| | Growth Hormone | 6 | 2016 | 96 | 1.880 |
Why?
| | Protein Conformation | 42 | 2017 | 863 | 1.750 |
Why?
| | Papillomavirus Vaccines | 3 | 2023 | 232 | 1.620 |
Why?
| | Protein Stability | 29 | 2020 | 162 | 1.570 |
Why?
| | Syringes | 8 | 2019 | 43 | 1.540 |
Why?
| | Viral Vaccines | 3 | 2022 | 94 | 1.500 |
Why?
| | Antibodies | 4 | 2021 | 398 | 1.400 |
Why?
| | Drug Packaging | 6 | 2020 | 41 | 1.340 |
Why?
| | Technology, Pharmaceutical | 7 | 2015 | 20 | 1.320 |
Why?
| | Temperature | 27 | 2024 | 637 | 1.280 |
Why?
| | Sucrose | 20 | 2019 | 99 | 1.240 |
Why?
| | Stress, Mechanical | 10 | 2023 | 467 | 1.240 |
Why?
| | Glass | 7 | 2019 | 43 | 1.210 |
Why?
| | Papillomavirus Infections | 2 | 2023 | 297 | 1.200 |
Why?
| | Thermodynamics | 27 | 2009 | 408 | 1.180 |
Why?
| | Immunoconjugates | 5 | 2019 | 104 | 1.170 |
Why?
| | Aluminum | 2 | 2024 | 38 | 1.170 |
Why?
| | Microspheres | 6 | 2016 | 124 | 1.160 |
Why?
| | Mice, Inbred BALB C | 14 | 2021 | 1250 | 1.130 |
Why?
| | Trehalose | 11 | 2022 | 30 | 1.110 |
Why?
| | Freezing | 17 | 2019 | 87 | 1.090 |
Why?
| | Adjuvants, Pharmaceutic | 4 | 2022 | 10 | 1.080 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2025 | 740 | 1.070 |
Why?
| | Emulsions | 6 | 2022 | 51 | 1.050 |
Why?
| | Complement Activation | 2 | 2019 | 384 | 1.030 |
Why?
| | Solubility | 19 | 2019 | 232 | 1.000 |
Why?
| | Delayed-Action Preparations | 5 | 2024 | 172 | 0.960 |
Why?
| | Lipase | 2 | 2025 | 66 | 0.940 |
Why?
| | Amyloid | 6 | 2021 | 85 | 0.930 |
Why?
| | Serum Albumin | 5 | 2015 | 149 | 0.930 |
Why?
| | Glycoproteins | 3 | 2022 | 338 | 0.920 |
Why?
| | Virion | 2 | 2023 | 83 | 0.860 |
Why?
| | Chromatography, Gel | 15 | 2016 | 126 | 0.840 |
Why?
| | Immunologic Factors | 2 | 2019 | 230 | 0.830 |
Why?
| | Drug Contamination | 7 | 2019 | 51 | 0.830 |
Why?
| | Capsid | 1 | 2023 | 90 | 0.830 |
Why?
| | Colloids | 7 | 2018 | 57 | 0.820 |
Why?
| | Bacteriophages | 1 | 2024 | 86 | 0.820 |
Why?
| | Protein Interaction Mapping | 2 | 2016 | 108 | 0.820 |
Why?
| | Root Cause Analysis | 1 | 2022 | 8 | 0.810 |
Why?
| | Inclusion Bodies | 4 | 2010 | 23 | 0.780 |
Why?
| | Surface Properties | 19 | 2019 | 397 | 0.770 |
Why?
| | Mice | 26 | 2023 | 16961 | 0.770 |
Why?
| | Interferon-gamma | 6 | 2003 | 772 | 0.750 |
Why?
| | Protein Structure, Secondary | 20 | 2014 | 341 | 0.750 |
Why?
| | Hydrogen-Ion Concentration | 19 | 2013 | 541 | 0.730 |
Why?
| | Capsid Proteins | 3 | 2021 | 90 | 0.730 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 39 | 0.730 |
Why?
| | Bacteriophage lambda | 1 | 2022 | 88 | 0.720 |
Why?
| | Animals | 45 | 2024 | 35391 | 0.720 |
Why?
| | Cell Survival | 1 | 2024 | 1076 | 0.700 |
Why?
| | Marburgvirus | 1 | 2020 | 10 | 0.700 |
Why?
| | Granulocyte Colony-Stimulating Factor | 4 | 2012 | 73 | 0.700 |
Why?
| | Recombinant Fusion Proteins | 5 | 2012 | 651 | 0.690 |
Why?
| | Spectrometry, Fluorescence | 10 | 2021 | 163 | 0.690 |
Why?
| | Biotechnology | 3 | 2010 | 39 | 0.690 |
Why?
| | Hydrostatic Pressure | 8 | 2011 | 18 | 0.680 |
Why?
| | Benzyl Alcohol | 6 | 2011 | 12 | 0.670 |
Why?
| | Fluorescent Dyes | 3 | 2018 | 312 | 0.670 |
Why?
| | Gels | 3 | 2016 | 81 | 0.650 |
Why?
| | Protein Denaturation | 16 | 2015 | 74 | 0.650 |
Why?
| | Polyvinyl Chloride | 1 | 2019 | 8 | 0.640 |
Why?
| | Drug Storage | 14 | 2021 | 57 | 0.640 |
Why?
| | Diethylhexyl Phthalate | 1 | 2019 | 15 | 0.640 |
Why?
| | Sialoglycoproteins | 5 | 2006 | 155 | 0.630 |
Why?
| | Ebola Vaccines | 1 | 2019 | 4 | 0.630 |
Why?
| | Benzothiazoles | 2 | 2018 | 32 | 0.590 |
Why?
| | Osmolar Concentration | 9 | 2016 | 166 | 0.590 |
Why?
| | Antigens | 4 | 2024 | 356 | 0.590 |
Why?
| | Insulin | 3 | 2021 | 2326 | 0.580 |
Why?
| | Spectrophotometry, Infrared | 14 | 2014 | 54 | 0.570 |
Why?
| | Hemoglobins | 6 | 1999 | 339 | 0.570 |
Why?
| | Buffers | 12 | 2014 | 56 | 0.560 |
Why?
| | Guanidine | 12 | 2014 | 21 | 0.560 |
Why?
| | Circular Dichroism | 17 | 2014 | 147 | 0.560 |
Why?
| | Kinetics | 19 | 2010 | 1645 | 0.550 |
Why?
| | Protein Structure, Tertiary | 15 | 2015 | 843 | 0.550 |
Why?
| | Humans | 82 | 2025 | 129627 | 0.540 |
Why?
| | Solutions | 15 | 2015 | 150 | 0.530 |
Why?
| | Scattering, Radiation | 10 | 2012 | 100 | 0.530 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2017 | 139 | 0.530 |
Why?
| | Antibodies, Viral | 4 | 2023 | 602 | 0.520 |
Why?
| | Complement System Proteins | 1 | 2019 | 318 | 0.520 |
Why?
| | Calorimetry, Differential Scanning | 9 | 2015 | 36 | 0.520 |
Why?
| | Polyesters | 6 | 2004 | 74 | 0.520 |
Why?
| | Aluminum Oxide | 2 | 2022 | 12 | 0.500 |
Why?
| | Rheology | 6 | 2019 | 90 | 0.500 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2018 | 253 | 0.490 |
Why?
| | Powders | 5 | 2022 | 43 | 0.490 |
Why?
| | Escherichia coli | 4 | 2022 | 767 | 0.480 |
Why?
| | Oncogene Proteins, Viral | 1 | 2015 | 22 | 0.480 |
Why?
| | Models, Chemical | 6 | 2012 | 263 | 0.470 |
Why?
| | Anthrax Vaccines | 1 | 2015 | 7 | 0.470 |
Why?
| | Ovalbumin | 1 | 2015 | 178 | 0.470 |
Why?
| | Chromatography, High Pressure Liquid | 10 | 2016 | 580 | 0.470 |
Why?
| | Crystallization | 8 | 2019 | 137 | 0.470 |
Why?
| | Lipid A | 1 | 2015 | 29 | 0.460 |
Why?
| | Databases, Factual | 2 | 2017 | 1269 | 0.460 |
Why?
| | Serum Albumin, Bovine | 3 | 2015 | 63 | 0.460 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 10 | 2011 | 81 | 0.450 |
Why?
| | Polyethylene Glycols | 10 | 2014 | 589 | 0.450 |
Why?
| | Pressure | 10 | 2009 | 237 | 0.450 |
Why?
| | Light | 10 | 2012 | 359 | 0.450 |
Why?
| | Unsupervised Machine Learning | 2 | 2024 | 18 | 0.440 |
Why?
| | Flow Cytometry | 2 | 2024 | 1159 | 0.430 |
Why?
| | Pharmaceutical Preparations | 4 | 2018 | 171 | 0.430 |
Why?
| | Ricin | 1 | 2013 | 8 | 0.420 |
Why?
| | Preservatives, Pharmaceutical | 2 | 2011 | 26 | 0.420 |
Why?
| | Algorithms | 5 | 2024 | 1616 | 0.410 |
Why?
| | Ultraviolet Rays | 3 | 2014 | 382 | 0.410 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 327 | 0.410 |
Why?
| | Protein Binding | 17 | 2018 | 2124 | 0.410 |
Why?
| | Stainless Steel | 2 | 2010 | 21 | 0.410 |
Why?
| | Polymers | 4 | 2004 | 477 | 0.410 |
Why?
| | Streptavidin | 2 | 2009 | 14 | 0.410 |
Why?
| | Vaccines, Subunit | 1 | 2013 | 48 | 0.400 |
Why?
| | Hydroxyethyl Starch Derivatives | 3 | 2009 | 8 | 0.400 |
Why?
| | Histidine | 2 | 2011 | 60 | 0.400 |
Why?
| | Drug Delivery Systems | 6 | 2011 | 333 | 0.400 |
Why?
| | Antibodies, Monoclonal, Humanized | 3 | 2012 | 757 | 0.390 |
Why?
| | Vaccines, Synthetic | 3 | 2009 | 126 | 0.390 |
Why?
| | Peptides | 1 | 2018 | 926 | 0.390 |
Why?
| | Enzyme Stability | 5 | 2009 | 69 | 0.390 |
Why?
| | Chemical Precipitation | 8 | 2009 | 37 | 0.390 |
Why?
| | Urea | 8 | 2018 | 76 | 0.380 |
Why?
| | Deuterium Exchange Measurement | 2 | 2011 | 29 | 0.380 |
Why?
| | Mice, Inbred C57BL | 10 | 2017 | 5455 | 0.380 |
Why?
| | Chromatography, Affinity | 1 | 2011 | 83 | 0.380 |
Why?
| | Transition Temperature | 5 | 2014 | 27 | 0.370 |
Why?
| | Static Electricity | 4 | 2020 | 116 | 0.360 |
Why?
| | Abatacept | 4 | 2012 | 46 | 0.350 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 267 | 0.350 |
Why?
| | Ribonuclease, Pancreatic | 2 | 2009 | 11 | 0.340 |
Why?
| | Methionine | 3 | 2012 | 155 | 0.330 |
Why?
| | Lactic Acid | 4 | 2011 | 298 | 0.330 |
Why?
| | Tungsten | 1 | 2009 | 30 | 0.320 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 5 | 2019 | 183 | 0.320 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2009 | 39 | 0.320 |
Why?
| | Microscopy, Electron, Transmission | 3 | 2021 | 146 | 0.320 |
Why?
| | Trastuzumab | 3 | 2019 | 100 | 0.320 |
Why?
| | Cellulase | 2 | 2006 | 31 | 0.310 |
Why?
| | Botulinum Toxins | 4 | 2010 | 39 | 0.310 |
Why?
| | Pharmaceutical Solutions | 6 | 2014 | 14 | 0.300 |
Why?
| | Albumins | 3 | 2013 | 103 | 0.300 |
Why?
| | Viscosity | 4 | 2018 | 90 | 0.290 |
Why?
| | Alkaline Phosphatase | 1 | 2009 | 146 | 0.290 |
Why?
| | DNA | 3 | 2023 | 1404 | 0.290 |
Why?
| | Mass Spectrometry | 4 | 2010 | 714 | 0.290 |
Why?
| | Carbon Dioxide | 2 | 2004 | 259 | 0.280 |
Why?
| | Interferon-alpha | 3 | 2013 | 194 | 0.280 |
Why?
| | Nanostructures | 3 | 2005 | 100 | 0.280 |
Why?
| | Hot Temperature | 7 | 2018 | 370 | 0.280 |
Why?
| | Microscopy, Electron, Scanning | 8 | 2005 | 196 | 0.270 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 858 | 0.270 |
Why?
| | Macrophages, Alveolar | 3 | 2006 | 389 | 0.270 |
Why?
| | Anilino Naphthalenesulfonates | 4 | 2018 | 10 | 0.270 |
Why?
| | Protein Unfolding | 4 | 2019 | 31 | 0.270 |
Why?
| | Oils | 2 | 2018 | 21 | 0.270 |
Why?
| | Chickens | 5 | 2017 | 189 | 0.260 |
Why?
| | Protein Biosynthesis | 1 | 2009 | 410 | 0.260 |
Why?
| | Filtration | 3 | 2014 | 67 | 0.260 |
Why?
| | Surface Tension | 2 | 2023 | 7 | 0.260 |
Why?
| | Quality Control | 3 | 2024 | 163 | 0.260 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 5 | 2010 | 136 | 0.250 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.250 |
Why?
| | Decanoic Acids | 1 | 2005 | 8 | 0.250 |
Why?
| | Anhydrides | 1 | 2005 | 18 | 0.250 |
Why?
| | Disulfides | 2 | 2005 | 97 | 0.250 |
Why?
| | Dimerization | 8 | 2014 | 192 | 0.240 |
Why?
| | Immunogenetic Phenomena | 2 | 2016 | 7 | 0.240 |
Why?
| | Quartz Crystal Microbalance Techniques | 1 | 2025 | 3 | 0.240 |
Why?
| | Subtilisins | 2 | 2005 | 10 | 0.240 |
Why?
| | 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2005 | 23 | 0.230 |
Why?
| | Amyloidosis | 2 | 2002 | 42 | 0.230 |
Why?
| | Trypsin Inhibitor, Kunitz Soybean | 1 | 2004 | 1 | 0.230 |
Why?
| | Injections, Subcutaneous | 2 | 2016 | 147 | 0.230 |
Why?
| | Protein Structure, Quaternary | 4 | 2011 | 122 | 0.230 |
Why?
| | Bacterial Vaccines | 3 | 2009 | 63 | 0.230 |
Why?
| | Phage Therapy | 1 | 2024 | 9 | 0.230 |
Why?
| | Female | 15 | 2021 | 68735 | 0.230 |
Why?
| | Hydrolysis | 1 | 2025 | 186 | 0.230 |
Why?
| | Platelet Aggregation | 1 | 2005 | 96 | 0.230 |
Why?
| | Supervised Machine Learning | 1 | 2024 | 17 | 0.220 |
Why?
| | Bone Cements | 1 | 2024 | 42 | 0.220 |
Why?
| | Cattle | 6 | 2015 | 977 | 0.220 |
Why?
| | Jurkat Cells | 1 | 2024 | 134 | 0.220 |
Why?
| | Desiccation | 2 | 2021 | 20 | 0.220 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2015 | 2011 | 0.220 |
Why?
| | Ions | 2 | 2002 | 66 | 0.210 |
Why?
| | Vitreous Body | 2 | 2003 | 109 | 0.210 |
Why?
| | Fibroblast Growth Factor 10 | 2 | 2013 | 23 | 0.200 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2003 | 171 | 0.200 |
Why?
| | Bias | 1 | 2024 | 197 | 0.200 |
Why?
| | Disaccharides | 3 | 2013 | 18 | 0.200 |
Why?
| | Diffusion | 3 | 2016 | 116 | 0.200 |
Why?
| | Vaccines, DNA | 1 | 2002 | 28 | 0.200 |
Why?
| | Peroxides | 1 | 2022 | 19 | 0.200 |
Why?
| | Gas Chromatography-Mass Spectrometry | 2 | 2019 | 130 | 0.190 |
Why?
| | Time Factors | 9 | 2021 | 6555 | 0.190 |
Why?
| | Membrane Glycoproteins | 1 | 2004 | 477 | 0.190 |
Why?
| | Fatty Acids | 1 | 2025 | 427 | 0.190 |
Why?
| | Gentamicins | 2 | 1998 | 54 | 0.180 |
Why?
| | Metals | 2 | 2013 | 123 | 0.180 |
Why?
| | Primates | 1 | 2022 | 120 | 0.180 |
Why?
| | Coloring Agents | 2 | 2002 | 77 | 0.180 |
Why?
| | Subtilisin | 1 | 2000 | 3 | 0.180 |
Why?
| | Mannitol | 3 | 2019 | 38 | 0.180 |
Why?
| | Tryptophan | 3 | 2013 | 177 | 0.180 |
Why?
| | Laboratories | 1 | 2021 | 108 | 0.170 |
Why?
| | Oxidation-Reduction | 7 | 2012 | 1028 | 0.170 |
Why?
| | Dextrans | 7 | 2000 | 84 | 0.170 |
Why?
| | Immunization | 1 | 2023 | 411 | 0.170 |
Why?
| | Isoniazid | 3 | 2006 | 63 | 0.170 |
Why?
| | High-Throughput Screening Assays | 1 | 2022 | 139 | 0.170 |
Why?
| | Spectrophotometry, Ultraviolet | 7 | 2014 | 84 | 0.170 |
Why?
| | Solvents | 4 | 2004 | 108 | 0.170 |
Why?
| | Models, Molecular | 4 | 2016 | 1491 | 0.170 |
Why?
| | Silicon Dioxide | 2 | 2015 | 109 | 0.170 |
Why?
| | Structure-Activity Relationship | 4 | 2011 | 545 | 0.160 |
Why?
| | Elasticity | 2 | 2018 | 195 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 834 | 0.160 |
Why?
| | Complement C4a | 1 | 2019 | 9 | 0.160 |
Why?
| | Complement C5a | 1 | 2019 | 70 | 0.160 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1843 | 0.160 |
Why?
| | beta-Lactamases | 1 | 1999 | 41 | 0.160 |
Why?
| | Plasticizers | 1 | 2019 | 14 | 0.160 |
Why?
| | Electron Spin Resonance Spectroscopy | 7 | 2000 | 91 | 0.160 |
Why?
| | Complement C3a | 1 | 2019 | 41 | 0.160 |
Why?
| | Thromboplastin | 1 | 1999 | 70 | 0.160 |
Why?
| | Pharmaceutic Aids | 1 | 1998 | 1 | 0.150 |
Why?
| | Complement Factor B | 1 | 2019 | 109 | 0.150 |
Why?
| | Complement C3 | 1 | 2019 | 209 | 0.150 |
Why?
| | Calibration | 1 | 2018 | 140 | 0.150 |
Why?
| | Models, Theoretical | 2 | 2018 | 546 | 0.150 |
Why?
| | Poliovirus Vaccine, Inactivated | 1 | 2018 | 28 | 0.150 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 399 | 0.140 |
Why?
| | Magnetic Resonance Spectroscopy | 4 | 2011 | 539 | 0.140 |
Why?
| | Dosage Forms | 1 | 1997 | 12 | 0.140 |
Why?
| | Photolysis | 2 | 2018 | 90 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 2 | 2014 | 523 | 0.140 |
Why?
| | Crystallography, X-Ray | 2 | 2009 | 438 | 0.140 |
Why?
| | Optical Imaging | 1 | 2018 | 56 | 0.140 |
Why?
| | Biophysical Phenomena | 1 | 2017 | 64 | 0.140 |
Why?
| | Software | 1 | 2021 | 608 | 0.130 |
Why?
| | Immune Tolerance | 2 | 2017 | 356 | 0.130 |
Why?
| | Viscoelastic Substances | 1 | 2016 | 10 | 0.130 |
Why?
| | Quaternary Ammonium Compounds | 3 | 2006 | 51 | 0.130 |
Why?
| | Suspensions | 1 | 2016 | 36 | 0.130 |
Why?
| | Anti-Bacterial Agents | 2 | 2024 | 1705 | 0.130 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2128 | 0.130 |
Why?
| | Immunoproteins | 1 | 2016 | 1 | 0.130 |
Why?
| | Microfluidic Analytical Techniques | 1 | 2017 | 72 | 0.130 |
Why?
| | Sodium Dodecyl Sulfate | 2 | 2006 | 22 | 0.130 |
Why?
| | Electrochemistry | 4 | 2016 | 79 | 0.120 |
Why?
| | Neutralization Tests | 1 | 2015 | 73 | 0.120 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 2 | 2014 | 179 | 0.120 |
Why?
| | Erythropoietin | 1 | 2015 | 88 | 0.110 |
Why?
| | Cresols | 1 | 2014 | 4 | 0.110 |
Why?
| | Phenol | 1 | 2014 | 19 | 0.110 |
Why?
| | Cricetinae | 2 | 2012 | 279 | 0.110 |
Why?
| | Glutathione Disulfide | 2 | 2005 | 32 | 0.110 |
Why?
| | Calorimetry | 2 | 2008 | 66 | 0.110 |
Why?
| | Micropore Filters | 1 | 2014 | 6 | 0.110 |
Why?
| | Insulin Aspart | 1 | 2014 | 26 | 0.110 |
Why?
| | Insulin Lispro | 1 | 2014 | 39 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 378 | 0.110 |
Why?
| | Parvovirus | 1 | 2014 | 13 | 0.110 |
Why?
| | Chromatography, Reverse-Phase | 1 | 2014 | 27 | 0.110 |
Why?
| | Biofouling | 1 | 2014 | 9 | 0.110 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2014 | 132 | 0.110 |
Why?
| | Cross Reactions | 1 | 2014 | 133 | 0.110 |
Why?
| | Immunoglobulin Light Chains | 3 | 2003 | 40 | 0.110 |
Why?
| | In Vitro Techniques | 4 | 2005 | 1087 | 0.100 |
Why?
| | Ferrous Compounds | 1 | 2013 | 23 | 0.100 |
Why?
| | Lactates | 1 | 1993 | 86 | 0.100 |
Why?
| | Silicates | 1 | 2012 | 15 | 0.100 |
Why?
| | Epitopes | 1 | 2015 | 472 | 0.100 |
Why?
| | Silicones | 1 | 2012 | 22 | 0.100 |
Why?
| | Sodium Chloride | 4 | 2013 | 137 | 0.100 |
Why?
| | Boron Compounds | 1 | 2012 | 22 | 0.100 |
Why?
| | Isoenzymes | 2 | 2001 | 301 | 0.100 |
Why?
| | Trace Elements | 1 | 2013 | 49 | 0.100 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 94 | 0.100 |
Why?
| | Mice, Nude | 1 | 2014 | 682 | 0.100 |
Why?
| | Carbonic Anhydrases | 1 | 1992 | 13 | 0.100 |
Why?
| | Antitubercular Agents | 2 | 2005 | 200 | 0.100 |
Why?
| | Spectrum Analysis | 3 | 2008 | 89 | 0.090 |
Why?
| | Polystyrenes | 1 | 2011 | 37 | 0.090 |
Why?
| | Phospholipids | 1 | 2013 | 216 | 0.090 |
Why?
| | Biopharmaceutics | 1 | 2011 | 2 | 0.090 |
Why?
| | Rats | 4 | 2010 | 5483 | 0.090 |
Why?
| | Spectrophotometry | 2 | 2001 | 57 | 0.090 |
Why?
| | Weight Gain | 2 | 2013 | 509 | 0.090 |
Why?
| | Interferon-beta | 1 | 2011 | 89 | 0.090 |
Why?
| | Carbohydrates | 4 | 2013 | 64 | 0.090 |
Why?
| | Salts | 2 | 2008 | 37 | 0.090 |
Why?
| | Binding Sites | 3 | 2011 | 1248 | 0.090 |
Why?
| | Hypophysectomy | 1 | 2010 | 15 | 0.090 |
Why?
| | Fermentation | 1 | 2010 | 25 | 0.080 |
Why?
| | Chromatography, Ion Exchange | 1 | 2010 | 52 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2009 | 2057 | 0.080 |
Why?
| | beta-Cyclodextrins | 1 | 2010 | 27 | 0.080 |
Why?
| | Tungsten Compounds | 1 | 2009 | 3 | 0.080 |
Why?
| | Steel | 1 | 2009 | 6 | 0.080 |
Why?
| | Aluminum Compounds | 1 | 2009 | 6 | 0.080 |
Why?
| | Microscopy, Atomic Force | 1 | 2010 | 118 | 0.080 |
Why?
| | Phase Transition | 1 | 2009 | 24 | 0.080 |
Why?
| | Molecular Sequence Data | 3 | 2009 | 2835 | 0.080 |
Why?
| | Computer Simulation | 2 | 2025 | 939 | 0.080 |
Why?
| | Oxides | 1 | 2009 | 41 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 3 | 2010 | 2395 | 0.080 |
Why?
| | Bacteriophage T4 | 1 | 2009 | 15 | 0.080 |
Why?
| | Factor XIII | 2 | 1998 | 5 | 0.080 |
Why?
| | Clostridium botulinum | 1 | 2008 | 4 | 0.080 |
Why?
| | Ultracentrifugation | 3 | 2009 | 48 | 0.080 |
Why?
| | Powder Diffraction | 1 | 2008 | 3 | 0.080 |
Why?
| | Immunization, Secondary | 1 | 2009 | 87 | 0.080 |
Why?
| | Biodegradation, Environmental | 2 | 2002 | 80 | 0.070 |
Why?
| | Succinates | 1 | 2008 | 23 | 0.070 |
Why?
| | Protein Renaturation | 2 | 2005 | 4 | 0.070 |
Why?
| | Protein Multimerization | 1 | 2009 | 179 | 0.070 |
Why?
| | Molecular Structure | 2 | 2006 | 481 | 0.070 |
Why?
| | Chemical Phenomena | 3 | 2014 | 82 | 0.070 |
Why?
| | Nanotechnology | 1 | 2009 | 121 | 0.070 |
Why?
| | Micelles | 2 | 2005 | 37 | 0.070 |
Why?
| | Molecular Conformation | 1 | 2007 | 141 | 0.070 |
Why?
| | Fractionation, Field Flow | 1 | 2007 | 4 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2009 | 330 | 0.070 |
Why?
| | Hydrogen | 3 | 2003 | 65 | 0.070 |
Why?
| | Deuterium | 3 | 2003 | 87 | 0.070 |
Why?
| | Actins | 2 | 2000 | 411 | 0.070 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2008 | 260 | 0.070 |
Why?
| | Congo Red | 2 | 2003 | 9 | 0.060 |
Why?
| | Dithiothreitol | 1 | 2005 | 17 | 0.060 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.060 |
Why?
| | Biometry | 1 | 2006 | 69 | 0.060 |
Why?
| | Poliomyelitis | 2 | 2018 | 36 | 0.060 |
Why?
| | Bacillus | 1 | 2005 | 15 | 0.060 |
Why?
| | alpha-Amylases | 1 | 2005 | 16 | 0.060 |
Why?
| | Trichoderma | 1 | 2005 | 27 | 0.060 |
Why?
| | Detergents | 1 | 2005 | 44 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1936 | 0.060 |
Why?
| | Immunoglobulin Variable Region | 2 | 2003 | 79 | 0.060 |
Why?
| | Hypoglycemic Agents | 1 | 2014 | 1221 | 0.060 |
Why?
| | Receptors, Interleukin-1 | 3 | 2005 | 218 | 0.060 |
Why?
| | Cell Line | 3 | 2006 | 2784 | 0.060 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2004 | 52 | 0.060 |
Why?
| | Data Interpretation, Statistical | 1 | 2006 | 337 | 0.060 |
Why?
| | Interleukin-11 | 1 | 2004 | 9 | 0.060 |
Why?
| | Fluorescence | 3 | 2013 | 155 | 0.060 |
Why?
| | Models, Biological | 2 | 2003 | 1724 | 0.060 |
Why?
| | Arginine | 1 | 2005 | 263 | 0.060 |
Why?
| | Nucleic Acid Conformation | 1 | 2007 | 706 | 0.050 |
Why?
| | Male | 5 | 2017 | 63671 | 0.050 |
Why?
| | Tacrine | 1 | 2002 | 1 | 0.050 |
Why?
| | Phenylephrine | 1 | 2002 | 75 | 0.050 |
Why?
| | Methods | 1 | 2002 | 64 | 0.050 |
Why?
| | Models, Statistical | 1 | 2006 | 625 | 0.050 |
Why?
| | Time | 1 | 2002 | 76 | 0.050 |
Why?
| | Tyrosine | 1 | 2003 | 223 | 0.050 |
Why?
| | Prodrugs | 1 | 2002 | 48 | 0.050 |
Why?
| | L-Selectin | 1 | 2001 | 25 | 0.050 |
Why?
| | Drug Interactions | 2 | 2004 | 395 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2001 | 119 | 0.050 |
Why?
| | Borates | 1 | 2000 | 3 | 0.040 |
Why?
| | Chemistry, Physical | 2 | 1997 | 37 | 0.040 |
Why?
| | Drug Design | 1 | 2002 | 158 | 0.040 |
Why?
| | Myoglobin | 1 | 2000 | 12 | 0.040 |
Why?
| | RNA | 1 | 2007 | 882 | 0.040 |
Why?
| | Nerve Growth Factor | 1 | 2000 | 25 | 0.040 |
Why?
| | Cytochrome c Group | 1 | 2000 | 42 | 0.040 |
Why?
| | Free Radical Scavengers | 1 | 2000 | 82 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2003 | 593 | 0.040 |
Why?
| | Electric Conductivity | 1 | 2000 | 94 | 0.040 |
Why?
| | Bence Jones Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Permeability | 1 | 2000 | 157 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 1999 | 10 | 0.040 |
Why?
| | Calcium | 1 | 2005 | 1212 | 0.040 |
Why?
| | Mitosporic Fungi | 1 | 1999 | 7 | 0.040 |
Why?
| | Bacteria | 1 | 2006 | 814 | 0.040 |
Why?
| | Hydrogels | 2 | 2021 | 630 | 0.040 |
Why?
| | Refractometry | 1 | 1999 | 28 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 569 | 0.040 |
Why?
| | Macromolecular Substances | 1 | 1999 | 216 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 130 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2022 | 3080 | 0.040 |
Why?
| | Centrifugation | 1 | 2018 | 30 | 0.040 |
Why?
| | Copper | 1 | 1999 | 108 | 0.040 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 1999 | 110 | 0.040 |
Why?
| | Phosphates | 2 | 2010 | 179 | 0.040 |
Why?
| | Self Administration | 1 | 2018 | 120 | 0.040 |
Why?
| | Potassium Chloride | 1 | 1997 | 39 | 0.040 |
Why?
| | Zinc | 1 | 2000 | 285 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 167 | 0.030 |
Why?
| | Interferons | 1 | 1998 | 191 | 0.030 |
Why?
| | Parkinson Disease | 1 | 2003 | 461 | 0.030 |
Why?
| | Povidone | 1 | 1996 | 5 | 0.030 |
Why?
| | Pregnancy | 1 | 2009 | 6417 | 0.030 |
Why?
| | Epoetin Alfa | 1 | 2015 | 6 | 0.030 |
Why?
| | Viral Proteins | 1 | 2018 | 327 | 0.030 |
Why?
| | Species Specificity | 1 | 2016 | 574 | 0.030 |
Why?
| | Biocompatible Materials | 1 | 1998 | 392 | 0.030 |
Why?
| | Isoelectric Point | 1 | 2014 | 23 | 0.030 |
Why?
| | Rabbits | 3 | 2001 | 779 | 0.030 |
Why?
| | Hypodermoclysis | 1 | 2013 | 4 | 0.030 |
Why?
| | Horses | 3 | 2003 | 107 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 2013 | 112 | 0.030 |
Why?
| | Acrylamides | 1 | 2013 | 57 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 202 | 0.030 |
Why?
| | Sulfites | 1 | 2013 | 7 | 0.030 |
Why?
| | Kidney | 1 | 2001 | 1386 | 0.030 |
Why?
| | Poliovirus | 1 | 2013 | 82 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2013 | 179 | 0.030 |
Why?
| | Cold Temperature | 1 | 2014 | 154 | 0.020 |
Why?
| | Lung | 1 | 2005 | 3938 | 0.020 |
Why?
| | Iodides | 1 | 1992 | 6 | 0.020 |
Why?
| | Phosphatidylcholines | 1 | 2013 | 145 | 0.020 |
Why?
| | Guanidines | 1 | 1992 | 36 | 0.020 |
Why?
| | Absorption | 2 | 2004 | 57 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 2003 | 426 | 0.020 |
Why?
| | Polyglycolic Acid | 1 | 2011 | 39 | 0.020 |
Why?
| | Interferon beta-1a | 1 | 2011 | 12 | 0.020 |
Why?
| | Particulate Matter | 1 | 2013 | 247 | 0.020 |
Why?
| | Heparin | 1 | 2013 | 254 | 0.020 |
Why?
| | Injections | 1 | 2011 | 174 | 0.020 |
Why?
| | 2-Hydroxypropyl-beta-cyclodextrin | 1 | 2010 | 6 | 0.020 |
Why?
| | Clostridium | 1 | 2009 | 14 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 514 | 0.020 |
Why?
| | Consumer Product Safety | 1 | 2009 | 32 | 0.020 |
Why?
| | Lipids | 1 | 2013 | 627 | 0.020 |
Why?
| | Deuterium Oxide | 2 | 1999 | 16 | 0.020 |
Why?
| | Cholesterol Oxidase | 1 | 1988 | 1 | 0.020 |
Why?
| | Spores, Bacterial | 1 | 2008 | 18 | 0.020 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1988 | 8 | 0.020 |
Why?
| | Alcohol Dehydrogenase | 1 | 1988 | 16 | 0.020 |
Why?
| | Rosaniline Dyes | 1 | 2007 | 12 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 1988 | 29 | 0.020 |
Why?
| | Peptide Mapping | 1 | 2007 | 63 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2007 | 109 | 0.020 |
Why?
| | Enzymes | 1 | 1988 | 65 | 0.020 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2005 | 10 | 0.020 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2005 | 11 | 0.020 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2007 | 175 | 0.020 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2005 | 67 | 0.020 |
Why?
| | Prions | 1 | 2006 | 46 | 0.020 |
Why?
| | Oxidants | 1 | 2006 | 109 | 0.020 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2004 | 26 | 0.010 |
Why?
| | Ultrafiltration | 1 | 2004 | 28 | 0.010 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2005 | 167 | 0.010 |
Why?
| | Molecular Weight | 1 | 2004 | 329 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2005 | 185 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2005 | 210 | 0.010 |
Why?
| | Base Sequence | 1 | 2007 | 2147 | 0.010 |
Why?
| | Ribonucleases | 1 | 2003 | 54 | 0.010 |
Why?
| | Cytochromes c | 1 | 2003 | 59 | 0.010 |
Why?
| | Synucleins | 1 | 2003 | 7 | 0.010 |
Why?
| | Osmotic Pressure | 1 | 2003 | 35 | 0.010 |
Why?
| | alpha-Synuclein | 1 | 2003 | 31 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2005 | 646 | 0.010 |
Why?
| | Cross-Linking Reagents | 1 | 2003 | 205 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 283 | 0.010 |
Why?
| | Thiazoles | 1 | 2002 | 117 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2005 | 745 | 0.010 |
Why?
| | Biological Transport | 1 | 2003 | 404 | 0.010 |
Why?
| | Protein Isoforms | 1 | 2003 | 388 | 0.010 |
Why?
| | Sorbitol | 1 | 2001 | 14 | 0.010 |
Why?
| | Betaine | 1 | 2001 | 75 | 0.010 |
Why?
| | Administration, Inhalation | 1 | 2002 | 667 | 0.010 |
Why?
| | Protein Subunits | 1 | 2001 | 233 | 0.010 |
Why?
| | Chromatography | 1 | 2000 | 25 | 0.010 |
Why?
| | Muscles | 1 | 2001 | 320 | 0.010 |
Why?
| | Enzyme Activation | 1 | 2001 | 813 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 372 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 1999 | 149 | 0.010 |
Why?
| | Swine | 1 | 2001 | 764 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2001 | 472 | 0.010 |
Why?
| | Drug Carriers | 1 | 1998 | 119 | 0.010 |
Why?
| | Lactose | 1 | 1996 | 7 | 0.010 |
Why?
| | Osteomyelitis | 1 | 1998 | 121 | 0.010 |
Why?
| | Cysteine | 1 | 1997 | 195 | 0.010 |
Why?
| | Oxidative Stress | 1 | 2003 | 1266 | 0.010 |
Why?
| | Fructose | 1 | 1996 | 106 | 0.010 |
Why?
| | Myocardium | 1 | 2001 | 980 | 0.010 |
Why?
| | Middle Aged | 1 | 1996 | 31136 | 0.010 |
Why?
| | Cyclic N-Oxides | 1 | 1995 | 29 | 0.010 |
Why?
| | Spin Labels | 1 | 1995 | 46 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2000 | 5756 | 0.000 |
Why?
| | Liver | 1 | 1988 | 1842 | 0.000 |
Why?
|
|
Randolph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|